Myelodysplastic Syndromes-Many New Drugs, Little Therapeutic Progress

被引：11
|
作者：
Tefferi, Ayalew [1 ]
机构：
[1] Mayo Clin, Div Hematol, Rochester, MN 55905 USA
来源：
MAYO CLINIC PROCEEDINGS | 2010年 / 85卷 / 11期
关键词：
ACUTE MYELOID-LEUKEMIA; STEM-CELL TRANSPLANTATION; IRON CHELATION-THERAPY; HIGH-RISK; PHASE-III; PROGNOSTIC-FACTORS; SCORING SYSTEM; SERUM FERRITIN; UNITED-STATES; 5Q DELETION;
D O I：
10.4065/mcp.2010.0502
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1042 / 1045
页数：4
相关论文
共 50 条
  • [1] Myelodysplastic syndromes: a review of therapeutic progress over the past 10 years
    Feld, Jonathan
    Belasen, Abigail
    Navada, Shyamala C.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (06) : 465 - 482
  • [2] Progress in Myelodysplastic Syndromes
    Garcia-Manero, Guillermo
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S286 - S292
  • [3] Immunomodulatory Drugs: New Options for the Treatment of Myelodysplastic Syndromes
    Castelli, Roberto
    Cassin, Ramona
    Cannavo, Antonino
    Cugno, Massimo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (01) : 1 - 7
  • [4] Myelodysplastic Syndromes: A New Decade
    Volpe, Virginia O.
    Garcia-Manero, Guillermo
    Komrokji, Rami S.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (01) : 1 - 16
  • [5] Current therapeutic approaches for patients with myelodysplastic syndromes
    Greenberg, Peter L.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 150 (02) : 131 - 143
  • [6] Review of therapeutic options and the management of patients with myelodysplastic syndromes
    Ozcan, Mehmet A.
    Ilhan, Osman
    Ozcebe, Osman I.
    Nalcaci, Meliha
    Gulbas, Zafer
    EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (02) : 165 - 189
  • [7] Unveiling Myelodysplastic Syndromes: Exploring Pathogenic Mechanisms and Therapeutic Advances
    Thalambedu, Nishanth
    Lal, Bhavesh Mohan
    Harbaugh, Brent
    Alapat, Daisy V.
    Gaddam, Mamatha
    Sanchez, Cesar Giancarlo Gentille
    Kumaran, Muthu
    Varma, Ankur
    CANCERS, 2025, 17 (03)
  • [8] Therapeutic Modalities for Patients with Lower-Risk Myelodysplastic Syndromes: Current Options and Future Directions
    Navada, Shyamala C.
    Silverman, Lewis R.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2011, 6 (01) : 5 - 12
  • [9] New therapeutic approaches in myelodysplastic syndromes: Hypomethylating agents and lenalidomide
    Loiseau, Clemenee
    Ali, Ashfaq
    Itzykson, Raphael
    EXPERIMENTAL HEMATOLOGY, 2015, 43 (08) : 661 - 672
  • [10] Myelodysplastic syndromes - diagnostic and therapeutic standards and new developments.
    Nolte, Florian
    Hofmann, Wolf-K.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2017, 142 (20) : 1502 - 1507
12345